fluorocarazolol

Known as: (18F)-fluorocarazolol, 1-(9H-carbazol-4-yloxy)-3-((1-(fluoromethyl)ethyl)amino)-2-propanol 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2005
0119942005

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
14. Van Heertum RL. Clinical diagnosis: major depressive disorder. In: Van Heertum RL. Tikofsky RS, eds. Cerebral SPECT imaging… (More)
  • table 1
  • figure 1
  • table 2
  • figure 3
  • figure 4
Is this relevant?
2005
2005
beta-Adrenergic receptor (beta-AR) concentration can be measured in vivo using positron emission tomography (PET) and the high… (More)
Is this relevant?
1997
1997
UNLABELLED S-1'-[18F]fluorocarazolol was administered to healthy volunteers to assess its potential for noninvasive measurement… (More)
Is this relevant?
1997
1997
UNLABELLED We evaluated the suitability of fluorocarazolol for in vivo studies of cerebral beta-adrenoceptors because (S)-1'-[18F… (More)
  • table 1
  • figure 1
  • table 2
  • figure 3
  • figure 4
Is this relevant?
1996
1996
Myocardial and pulmonary beta-adrenoceptors can be imaged with 2-(S)-(-)-(9H-carbazol-4-yl-oxy)-3-[1-(fluoromethyl)ethyl]amino-2… (More)
Is this relevant?
1995
1995
The biodistribution of S-(-)-4-(2-hydroxy-3-(1'-[18F]fluoroisopropyl)- aminopropoxy)carbazole ([18F]S-fluorocarazolol, a non… (More)
Is this relevant?
1994
1994
New beta-adrenergic receptor antagonists, 2-(R)-(+)- and 2-(S)-(-)-1-(9H-carbazol-4-yl-oxy)-3-[[1-(fluoromethyl)ethyl]amino ]-2… (More)
Is this relevant?